← 홈

프로그램 비교

타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-6 · 마지막 9월 2일

현재 선택: 1개 · 임상 갱신 필요 1개

프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.

프로그램 선택

API CSV16행 · 1개 프로그램
OverviewToxicologyClinical

표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.

항목
CGTStandard DatabasestalePreclinical
Gene analysis (Gene analysis)
Central South University·Homozygous Familial Hypercholester…
31 trials
Overview
Program
Gene analysis
Overview
Company
Central South University
Overview
Modality
CGT
Overview
Target
Homozygous Familial Hypercholesterolemia
Overview
Indication
Homozygous Familial Hypercholesterolemia
Overview
Phase
PRECLINICAL
Overview
Status
ACTIVE
Overview
Content status
Standard Database
Overview
Data Confidence
Data Confidence · Medium
Overview
Development Signal
Development Signal · Watch
Overview
Approval status
Investigational
Toxicology
Major finding
Mechanisms and strategies of Bacillus subtilis Bs1 for controlling Chinese fir anthracnose.. Cunninghamia lanceolata is a valuable timber species whose productivity is threatened by anthracnose caused by C. gloeosporioides. To develop a sustainable biocontrol strategy, the antagonistic bacterium Bs1 was isolated and identified as Bacillus subtilis. Bs1 showed a 66% inhibition rate against C. gloeo…
Clinical
Safety signal
Mechanisms and strategies of Bacillus subtilis Bs1 for controlling Chinese fir anthracnose.. Cunninghamia lanceolata is a valuable timber species whose productivity is threatened by anthracnose caused by C. gloeosporioides. To develop a sustainable biocontrol strategy, the antagonistic bacterium Bs1 was isolated and identified as Bacillus subtilis. Bs1 showed a 66% inhibition rate against C. gloeo…
Clinical
Result source
ClinicalTrials.gov NCT04320888
Clinical
Program phase
PRECLINICAL
Clinical
Trial ref
NCT04320888